New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties.
about
Nanomechanical in situ monitoring of proteolysis of peptide by Cathepsin BFabrication and intracellular delivery of doxorubicin/carbonate apatite nanocomposites: effect on growth retardation of established colon tumorDelivery of cancer therapeutics using nanotechnologyWater-Soluble, Biocompatible Polyphosphazenes with Controllable and pH-Promoted Degradation Behavior.Recent trends in targeted anticancer prodrug and conjugate design.Macromolecular therapeuticsDevelopment and evaluation of pH-responsive single-walled carbon nanotube-doxorubicin complexes in cancer cells.Bioengineering strategies for designing targeted cancer therapiesComparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers.Acid-Sensitive Magnetic Nanoparticles as Potential Drug Depots.Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediateAcidic hydrolysis of N-Ethoxybenzylimidazoles (NEBIs): potential applications as pH-sensitive linkers for drug delivery.Expert opinion: Responsive polymer nanoparticles in cancer therapyNovel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis.Epirubicin-[Anti-HER2/neu] Synthesized with an Epirubicin-(C13-imino)-EMCS Analog: Anti-Neoplastic Activity against Chemotherapeutic-Resistant SKBr-3 Mammary Carcinoma in Combination with Organic Selenium.Drug delivery strategies for common orofacial diseases.Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy (Review)Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery.Biological stimuli and biomolecules in the assembly and manipulation of nanoscale polymeric particles.Magnetically modulated nanosystems: a unique drug-delivery platform.Acid-degradable polymers for drug delivery: a decade of innovation.Classification of stimuli-responsive polymers as anticancer drug delivery systems.HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.Overcoming multidrug resistance using folate receptor-targeted and pH-responsive polymeric nanogels containing covalently entrapped doxorubicin.In vitro and in vivo chemo-phototherapy of magnetic TiO2 drug delivery system formed by pH-sensitive coordination bond.Galactosylated 2-hydroxypropyl methacrylamide-s-3-guanidinopropyl methacrylamide copolymer as a small hairpin RNA carrier for inhibiting human telomerase reverse transcriptase expression.Synergistic combination therapy using a lipid shell-droplet core nanosphere with tunable thickness.Rational design of polyion complex nanoparticles to overcome cisplatin resistance in cancer therapy.HPMA copolymer conjugates of DOX and mitomycin C for combination therapy: physicochemical characterization, cytotoxic effects, combination index analysis, and anti-tumor efficacy.Complexation of cell-penetrating peptide-polymer conjugates with polyanions controls cells uptake of HPMA copolymers and anti-tumor activity.In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites.Optical properties and application of a reactive and bioreducible thiol-containing tetramethylrhodamine dimer.HPMA based macromolecular therapeutics: internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer composition.Comparison of hydrazone heterobifunctional cross-linking agents for reversible conjugation of thiol-containing chemistry.Design of smart HPMA copolymer-based nanomedicines.Facile synthesis of multivalent folate-block copolymer conjugates via aqueous RAFT polymerization: targeted delivery of siRNA and subsequent gene suppression.Folate-decorated succinylchitosan nanoparticles conjugated with doxorubicin for targeted drug delivery.Metal-Organic Polyhedron Capped with Cucurbit[8]uril Delivers Doxorubicin to Cancer CellsAntibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.Subcellular co-delivery of two different site-oriented payloads for tumor therapy.
P2860
Q28475765-3F62D738-D57C-4971-8E54-EC89AA7DDFECQ28486235-76BAF18B-EE56-4A4C-98AB-620D02BECE3AQ30446963-DEBB8900-D994-4FEE-AC69-2DEDB55D85CAQ30799901-C9BCE7F7-3729-4F75-9D8E-4D0A0F8B319FQ33573762-F9F6FE83-8753-46CE-9809-174211855C20Q34079574-497D127D-A170-4245-85E5-8B6B9BB86C6BQ34087482-39CDA549-83BD-479A-8ABF-FFB0F222D6D6Q34194191-6587F47D-2DD4-4CE2-8032-E21B6A74C617Q34445374-49C0C431-ACC8-46CC-A764-B26BB278EF03Q35099072-D8573565-9307-453C-B0A2-BB62B825C4C7Q35180943-D7683B6B-0F01-4952-B043-51B97B1526AFQ35678773-7C5E9FE7-0708-4D58-8DD1-1E9BA3255CF6Q35718515-4BC17E2D-4520-4ED0-9D37-C9A22CFFBE5BQ35769042-2883DBB0-A689-4855-A615-07866546799EQ35896698-4BBB5C55-8784-4DF2-82BC-5E1284D1E3F4Q36627793-AF07EB19-7A6E-403A-95D3-B72ECA3ECD71Q36643541-A39D86B8-89DD-4B02-A9BF-7226FFBE171BQ37121790-56C77929-FB8C-4128-94BD-B41E8E144226Q37396540-11A21221-4D84-4B26-BE39-35D6C904D17EQ37617371-2862E1AE-D7A8-4DE3-B008-BFC0A38EED81Q38074172-4AFC07D2-8EA5-49E1-B6B0-276EED13314CQ38189091-D418D7C4-FB93-4757-9B1D-C6E5A4B657FAQ38626421-0D376CE4-0974-4B92-9FD2-3F78FC27CE27Q38681692-A58CBEA4-E94D-473A-9438-13EF09E68458Q38849605-36027BD6-3200-421A-B006-7AC8592F845AQ38979424-340747AF-8840-436B-8AAD-B9E1BA33BEC7Q38990290-17CE29D9-930C-4FD6-A899-032F4C35C234Q39043200-627D5C73-392B-4AF1-889A-6BB11392A644Q39096548-DB12A344-5822-4F77-BFBA-5221F0D4D228Q39098106-06B361EE-F856-4643-AFBA-0421326537B7Q39643108-268EED43-FB58-4242-AB57-6564EE4818A1Q39878851-92E1F16D-D9D0-4223-A312-ED070703B36EQ40210611-C99964CB-D012-4F29-A83E-D71C3173BAF9Q42407631-FBB06335-1C15-4045-8BD0-CE731E5A11CDQ42553783-136563CF-6D9E-4C12-AA3F-AC6BD45F9ECEQ42733240-116C2FFB-2FF7-4922-BDF1-2C4F5C92C7DEQ42817828-E4195691-8F87-4CC7-9C34-1A9EBBB58152Q42859704-65CD68DD-2D7D-429D-ABE6-68BDCD2C8DF3Q45204007-E62EF868-FC2A-455A-9673-BC2D3D5FD045Q48372665-7FCFB306-B3CE-461B-96DE-5584925F8521
P2860
New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
New HPMA copolymers containing ...... in vivo biological properties.
@en
New HPMA copolymers containing ...... in vivo biological properties.
@nl
type
label
New HPMA copolymers containing ...... in vivo biological properties.
@en
New HPMA copolymers containing ...... in vivo biological properties.
@nl
prefLabel
New HPMA copolymers containing ...... in vivo biological properties.
@en
New HPMA copolymers containing ...... in vivo biological properties.
@nl
P2093
P1476
New HPMA copolymers containing ...... in vivo biological properties.
@en
P2093
P304
P356
10.1016/S0168-3659(01)00281-4
P407
P577
2001-05-01T00:00:00Z